Matthew Habgood is a highly experienced computational chemist with a robust background in drug design and research. Currently serving as a Senior Computational Chemist at Cresset Software and Discovery since June 2022, Matthew previously worked as a Principal Computational Chemist and Senior Computational Chemist at a private research organization from March 2019 to June 2022, focusing on large-scale simulations related to pharmaceutical mechanisms. Prior to this, Matthew held various positions, including Senior Scientist 1 at Evotec and Visiting Researcher at University College London, overseeing PhD students and enhancing computer-aided drug design methodologies. Matthew's academic credentials include a DPhil in Physics from the University of Oxford and an MSci in Chemistry from Imperial College London.